Related Policies
• Biofeedback as a Treatment of Chronic Pain Any of the following diagnostic procedures may be considered medically necessary in the diagnosis of temporomandibular joint (TMJ) dysfunction:
• Diagnostic x-ray, tomograms, and arthrograms
• Computed tomography (CT) scan or magnetic resonance imaging (MRI) (in general, CT scans and MRIs are reserved for presurgical evaluations)
• Cephalograms (x-rays of jaws and skull)
• Pantograms (x-rays of maxilla and mandible) (Cephalograms and pantograms should be reviewed on an individual basis.)
Any of the following diagnostic procedures are considered investigational in the diagnosis of TMJ dysfunction:
• Arthroscopy of the TMJ for purely diagnostic purposes • Ultrasound imaging/sonogram
Nonsurgical Treatments
Either of the following nonsurgical treatments may be considered medically necessary in the treatment of TMJ dysfunction:
• Intraoral removable prosthetic devices/appliances (encompassing fabrication, insertion, adjustment)
• Pharmacologic treatment (such as anti-inflammatory, muscle relaxing, analgesic medications)
Any of the following nonsurgical treatments are considered investigational in the treatment of TMJ dysfunction:
• Acupuncture* • Percutaneous electrical nerve stimulation (PENS)
• Physical therapy*, including diathermy, infrared and heat and cold treatment, and manipulation
• Transcutaneous electrical nerve stimulation (TENS)
• Ultrasound *See Benefit Application Section
Surgical Treatments
Any of the following surgical treatments may be considered medically necessary in the treatment of TMJ dysfunction:
• Arthrocentesis
• Manipulation for reduction of fracture or dislocation of the TMJ
• Arthroscopic surgery in patients with objectively demonstrated (by physical examination or imaging) internal derangements (displaced discs) or degenerative joint disease who have failed conservative treatment
• Open surgical procedures (when TMJ dysfunction is the result of congenital anomalies, trauma, or disease in patients who have failed conservative treatment) including, but not limited to arthroplasties; condylectomies; meniscus or disc plication and disc removal.
Policy Guidelines
Orthodontia (dental services to correct irregularities or malocclusion of the teeth) for the medical treatment to alleviate TMJ is not a covered benefit per Blue Shield of California Evidence of Coverage (EOC). Refer to the subscribers dental or orthodontia benefit for further reference.
The following diagnoses/symptoms may be associated with TMJ dysfunction (list is not all inclusive):
• Cranial-cervical syndrome Claims may be received for psychiatric/psychological visits in relation to TMJ dysfunction, as this condition may be psychosomatic in origin, resulting from tension or stress. Bruxism is a common symptom of tension, which may lead to symptoms suggestive of TMJ syndrome.
Benefit Application
Benefit determinations should be based in all cases on the applicable contract language. To the extent there are any conflicts between these guidelines and the contract language, the contract language will control. Please refer to the member's contract benefits in effect at the time of service to determine coverage or noncoverage of these services as it applies to an individual member.
Some state or federal mandates (e.g., Federal Employee Program (FEP)) prohibit Plans from denying Food and Drug Administration (FDA) -approved technologies as investigational. In these instances, plans may have to consider the coverage eligibility of FDA-approved technologies on the basis of medical necessity alone.
Rationale Background
Temporomandibular joint (TMJ) dysfunction (also known as TMJ disorders) refers to a cluster of problems associated with the TMJ and musculoskeletal structures. The etiology of TMJ disorders remains unclear and is believed to be multifactorial. TMJ disorders are often divided into 2 main categories: articular disorders (e.g., ankylosis, congenital or developmental disorders, disc derangement disorders, fractures, inflammatory disorders, osteoarthritis, joint dislocation) and masticatory muscle disorders (e.g., myofascial pain, myofibrotic contracture, myospasm, neoplasia).
There are no generally accepted criteria for diagnosing TMJ disorders. It is often a diagnosis of exclusion and involves physical examination, patient interview, and dental record review. Diagnostic testing and radiologic imaging is generally only recommended for patients with severe and chronic symptoms.
Symptoms attributed to TMJ dysfunction are varied and include but are not limited to clicking sounds in the jaw; headaches; closing or locking of the jaw due to muscle spasms (trismus) or displaced disc; pain in the ears, neck, arms, and spine; tinnitus; and bruxism (clenching or grinding of the teeth).
For many patients, symptoms of TMJ dysfunction are short-term and self-limiting.
Conservative treatments, such as eating soft foods, rest, heat, ice, and avoiding extreme jaw movements, and anti-inflammatory medication, are recommended before consideration of more invasive and/or permanent therapies, such as surgery.
Note: Low-level laser therapy for TMJ is addressed in Blue Shield of California Medical Policy: Low-Level Laser Therapy.
Regulatory Status
At least 1 joint vibration analysis device has received clearance from the U.S. Food and Drug Administration (FDA). In February 2009, the BioEMG III Joint Vibration Analysis device (BioResearch Associates, Brown Deer, WI) was cleared for marketing by the FDA through the 510(k) process. The intended use of the device is to record and display sounds and vibrations from the TMJ and to aid clinicians in the analysis of joint sound and vibrations. FDA Product Code: KZM.
Literature Review
Recent literature searches have concentrated on identifying systematic reviews and meta-analyses. For treatment of temporomandibular (TMJ) disorders, the focus has been on studies that compared novel treatments with conservative interventions and/or placebo controls (rather than no-treatment control groups) and that reported pain reduction and/or functional outcomes (e.g., jaw movement).
Diagnosis of TMJ Dysfunction
Several systematic reviews of the literature on specific techniques for diagnosing TMJ were identified and are described next.
Magnetic Resonance Imaging
A systematic review on magnetic resonance imaging (MRI) was published in 2009 by Koh et al and included 23 studies.(1) Eight of the 23 studies found a relationship between a clinical and MRI diagnosis. The authors found substantial variability in study design, methods of clinical examination, and diagnostic criteria and therefore could not pool study findings. The Koh et al review concluded that there is no clear evidence of a relationship between clinical and MRI diagnosis, and findings and additional studies using improved methodologies are needed.
Ultrasound
A 2009 systematic review identified 20 studies evaluating ultrasound for diagnosing TMJ disorders; all studies evaluated disc displacement and several additionally considered osteoarthrosis and/or joint effusion. (2) The reported sensitivity of ultrasound to detect disc displacement, compared with the reference standard (MRI in most studies), ranged from 31% to 100%, and the specificity ranged from 30% to 100%. The investigators stated that, even when changes in ultrasound technology over time were taken into consideration, study findings were contradictory. They noted unexplained differences between studies conducted by the same group of researchers. The authors concluded that additional progress needs to be made in standardizing ultrasound assessment of the TMJ joint before this can be considered an accurate tool for diagnosing TMJ disorders.
Surface Electromyography
The authors of a 2006 systematic review on surface electromyography found a lack of literature on the accuracy of this method of diagnosis, compared with a criterion standard (i.e., comprehensive clinical examination and history-taking).
(3) They concluded that there is insufficient evidence that electromyography can accurately separate people with facial pain from those without pain but that the technique may be useful in a research setting.
Joint Vibration Analysis
In 2013, Sharma et al published a systematic review of literature on joint vibration analysis for diagnosis of TMJ disorders.(4) The authors identified 15 studies that evaluated the reliability and/or diagnostic accuracy of joint vibration analysis compared with a reference standard. Methodologic limitations were identified in all the studies. These limitations included the absence of well-defined diagnostic criteria, use of a nonvalidated system for classifying disease progression, variability within studies in the reference standard, and lack of blinding. In the 14 studies reporting on diagnostic accuracy, there was a wide range of reported values, with sensitivity ranging from 50% to 100% and specificity ranging from 59% to 100%.
Treatment of TMJ Dysfunction
A 2010 article by List and Axelsson was a review of systematic reviews on treatments for TMJ dysfunction published through August 2009.(5) The authors identified 30 reviews; there were 23 qualitative systematic reviews and 7 meta-analyses. Eighteen of the systematic reviews included only randomized controlled trials (RCTs), 3 included casecontrol studies, and 9 included a mixture of RCTs and case series. There was inconsistency in how TMJ disorders were defined in the primary studies and systematic reviews, and several of the reviews addressed the related diagnoses of bruxism, disc replacements, and myofascial pain. Twenty-nine of the systematic reviews had pain intensity or pain reduction as the primary outcome measure, and 25 reported clinical outcome measures such as jaw movement or jaw tenderness on palpation. The authors divided the treatments into 5 categories (some studies were included in more than 1 category). These categories and the main findings are as follows:
1. Occlusal appliances, occlusal adjustment, and orthodontic treatment (10 articles): 6 systematic reviews did not find significant benefit compared with other treatments, 4 found no benefit compared with a placebo device, and 3 found that occlusal therapy was better than no treatment.
2. Physical therapy including acupuncture, transcutaneous electrical nerve stimulation (TENS), exercise and mobilization (8 articles): 4 reviews found no significant benefit of acupuncture over other treatments, 1 found no difference between acupuncture and placebo treatment, and 3 found that acupuncture was better than no treatment.
3. Pharmacologic treatment (7 articles): treatments found to be superior to placebo were analgesics (2 reviews), clonazepam or diazepam (3 reviews), antidepressants (4 reviews) and hyaluronate (1 review). The last review also found hyaluronate and corticosteroids to have a similar effect.
4. Maxillofacial surgery (4 articles): 3 reviews evaluated surgery for patients with disc displacements and the fourth addressed orthognathic surgery in patients with TMJ disorder. Reviews of surgical treatments generally included lower level evidence (e.g., case series) and did not always compare surgery with a control condition. One systematic review found a similar effect of arthrocentesis, arthroscopy, and physical therapy.
5.
Behavioral therapy and multimodal treatments (6 articles): 2 reviews found biofeedback to be better than active control or no treatment, 1 review found a combination of biofeedback and cognitive-behavioral therapy to be better than no treatment, and 2 found a combination of biofeedback and relaxation to be better than no treatment. One review found that the effects of biofeedback and relaxation were similar.
Overall, the authors concluded that there is insufficient evidence that electrophysical modalities and surgery are effective for treating TMJ dysfunction. They found some evidence that occlusal appliances, acupuncture, behavioral therapy, jaw exercise, postural training, and some medications can be effective in reducing pain for patients with TMJ disorders. However, the authors note that most of the systematic reviews they examined included primary studies with considerable variation in methodologic quality, and thus, it is not possible to make definitive conclusions about the effectiveness of any of the treatments.
Representative systematic reviews and meta-analyses on specific treatments for TMJ disorders are summarized next.
Intraoral Appliances/Devices
A 2010 systematic review searched for RCTs on intraoral treatment of TMJ disorders and identified 47 publications on 44 trials.(6) Intraoral appliances included soft and hard stabilization appliances, anterior positioning appliances, anterior bite appliances, and soft resilient appliances. Studies compared 2 types of devices or compared 1 device with a different treatment (e.g., acupuncture or biofeedback). None of the studies evaluated use of 1 device during the day and a different device during the night. The primary outcome of the meta-analysis was pain. Pain was measured differently in the studies, and the authors defined a successful outcome as at least a 50% reduction in pain on a self-report scale or at least an "improved" status when pain was measured by subjective report of status. Ten RCTs were included in a meta-analysis; the others were excluded because they did not measure pain, there were not at least 2 studies using similar devices or control groups, or data were not usable in a pooled analysis. A pooled analysis of 7 RCTs with 385 patients evaluating hard stabilization appliances and using palatal nonoccluding appliances as a control found a significantly greater reduction in pain with hard appliances (odds ratio [OR], 2.45; 95% confidence interval [CI], 1.56 to 3.86; p<0.001). A pooled analysis of 3 studies with 216 patients did not find a significant effect of hard appliances compared with a no-treatment control group (OR=2.14; 95% CI, 0.80 to 5.75; p=0.12) (p=0.86).
Stabilization Splints
In 2012, Ebrahim et al identified 11 RCTs comparing splint therapy for TMJ with minimal or no therapy. (7) Nine of the 11 studies used stabilization splints, 1 used soft splints and 1 used an anterior repositioning appliance. The authors used the GRADE system to rate study quality. Nine studies did not report whether allocation was concealed, and 6 studies did not report masking of outcome assessors. Length of follow-up in the studies ranged from 6 to 52 weeks. A pooled analysis of study findings found that splint therapy was significantly associated with a reduction in reported pain compared with minimal or no intervention (standardized mean difference [SMD], -0.93; 95% CI, -1.33 to -0.53). Using a visual analog scale (VAS) to measure pain, splint therapy was associated with an 11.5 mm lower mean VAS score (95% CI, -16.5 to -6.6 mm). There were not statistically significant differences between groups in quality of life or depression scores. An earlier meta-analysis by Al-Ani et al, published in 2004, identified 12 RCTs that compared stabilization splint therapy for TMJ dysfunction with a control intervention.(8) (The control group was not limited to minimal or no intervention as in the Ebrahim review, previously described). There was wide variability in the comparison interventions and no standardization of outcomes; thus, results of the studies were not pooled.
Orthodontic Services
A 2010 Cochrane review by Luther et al did not identify any RCTs evaluating orthodontic treatment for treating TMJ disorders and thus concluded that there is insufficient evidence on the efficacy of orthodontics.(9) They defined orthodontic treatment as appliances that would induce stable tooth movement for a sufficient period of time to bring about permanent change in tooth position.
Acupuncture
A 2011 meta-analysis identified 7 sham-controlled RCTs on acupuncture for treating TMJ disorders. (10) The studies included a total of 141 patients. Sample sizes of individual studies ranged from 7 to 28. Four studies used a single acupuncture session, and the other 3 used 6 to 12 sessions. All 7 studies reported change in pain intensity as assessed by VAS. In 6 of the studies, pain intensity was measured immediately after treatment, the seventh measured pain after 16 weeks. A pooled analysis of findings from 5 studies (n=107) found a statistically significant improvement in pain intensity, as measured by VAS. The pooled weighted mean difference (WMD) in pain intensity was -13.63 (95% CI, -21.16 to -6.10; p<0.001). In a subgroup analysis, a pooled analysis of 4 studies (n=89) found acupuncture to be superior to a nonpenetrating sham acupuncture (WMD= -13.73; 95% CI, -21.78 to -5.67; p<0.001). A pooled analysis of 2 studies (n=18) did not find a significant difference in efficacy between acupuncture and a penetrating sham acupuncture (WMD= -12.95; 95% CI, -34.05 to 8.15; p=0.23). The latter analysis may have been underpowered. The authors noted that previous studies have found that a 24.2-mm change in pain assessed by a 100-mm VAS represents a clinically significant difference and that only 2 of the included studies had a change of 24.2 mm or more. The evidence on acupuncture is limited by the small number of studies, small sample sizes, and, in most studies, assessment of effectiveness only immediately posttreatment.
Behavioral Therapy/Psychosocial Interventions
In 2011, the Cochrane collaboration published a systematic review of psychosocial interventions for managing chronic orofacial pain. (11) The review included 15 RCTs on TMJ disorders; however, only 9 of the trials had data that were suitable for pooling. The others were excluded due to study design and/or because they only reported data graphically. The 9 studies had a high degree of heterogeneity (e.g., used different interventions, reported different outcomes or outcomes over different time periods). The interventions addressed in the studies included cognitive-behavioral therapy (CBT) alone (4 studies), biofeedback alone (2 studies), combination of CBT and biofeedback (2 studies), and physical self-regulation (1 study). Short-term follow-up was defined as 3 months or less, and long-term as more than 3 months. Due to heterogeneity among studies, an overall pooled analysis of data from the 7 studies on short-term pain could not be performed. The investigators were able to pool data from the 2 studies on combined CBT and biofeedback compared with usual care; the analysis found a statistically significant difference favoring usual care (SMD=0.46; 95% CI, 0.02 to 0.90). A pooled analysis of the 2 studies on biofeedback alone did not find a significant benefit of the intervention (SMD=-0.41; 95% CI, -1.06 to 0.25). In a pooled analysis of data from the 7 studies on long-term change in pain, there was a statistically significant difference in favor of psychosocial interventions compared with control interventions (SMD=-0.34; 95% CI, -0.50 to -0.18). Pooled analyses of 4 studies on CBT alone and 3 studies on CBT plus biofeedback also significantly favored the group receiving the psychosocial intervention. Only 1 study each reported long-term pain with biofeedback alone and with physical self-regulation. A more recent systematic review was published in 2013, but the authors did not pool study findings due to heterogeneity among interventions and study designs. In a 2013 systematic review, Vos et al identified 3 RCTs with a total of 222 patients comparing the efficacy of lavage of the TMJ (i.e., arthrocentesis or arthroscopy) with nonsurgical TMJ treatment. (14) Although they assessed the quality of the studies to be adequate, only 1 study stated that allocation to treatment group was concealed, and 2 studies did not explicitly state that an intention-to-treat analysis was used. The 2 primary outcomes considered were change in pain and maximal mouth opening (MMO) at 6 months compared with baseline. Pain was measured by VAS. Pooled analysis of data from the 3 trials found a statistically significant reduction in pain at 6 months with lavage versus nonsurgical therapy (SMD=-1.07; 95% CI, -1.38 to -0.76). There was not a statistically significant difference in the efficacy of the 2 treatments for the other outcome variable, MMO (SMD=-0.05; 95% CI, -0.33 to 0.23).
Hyaluronic Acid
There are several systematic reviews of studies on hyaluronic acid for treating TMJ disorders. Outcomes were categorized as symptoms, which reflected subjective feeling and the judgment of the patients, and clinical signs, which reflected objective judgment of the observer. A meta-analysis of 2 trials did not find a statistically significant difference between hyaluronic acid and placebo on short-term (<3 months) improvement in symptoms (risk ratio [RR], 1.24; 95% CI, 0.72 to 2.14). Similarly, a pooled analysis of 3 trials did not find a significant difference between hyaluronic acid and placebo on short-term improvement of clinical signs (RR=1.69; 95% CI, 0.80 to 3.57). However, a pooled analysis of 2 studies found a statistically significant between-group difference in long-term effect on clinical signs (RR=1.71; 95% CI, 1.05 to 2.77) (long-term was defined as ≥3 months). For the comparison between hyaluronic acid and glucocorticoids, only short-term data were available for pooling. There were no significant differences between groups on short-term improvement in symptoms (2 studies; RR=0.99; 95% CI, 0.84 to 1.17) or shortterm improvement in clinical signs (3 studies; RR=0.91; 95% CI, 0.66 to 1.25). Data were not pooled for studies on combination treatment (hyaluronic acid plus arthroscopy or arthrocentesis). The investigators concluded that there is insufficient consistent evidence to draw conclusions on the use of hyaluronate for treating patients with TMJ disorders.
Most of the published RCTs evaluating hyaluronic acid for treating TMJ disorders had small sample sizes, short follow-up times, and/or lack of blinding. Representative RCTs published through May 2012 are described next. RCTs with larger sample sizes and stronger methodology were selected for description. 12%) were excluded from the analysis because they were found not to meet eligibility criteria. No significant differences in outcomes were seen for the DJD group. In the DDN group, there were significant between-group differences through 1 month, favoring the hyaluronic acid group. The number of patients in the DDN group who completed follow-up after 1 month was insufficient to draw meaningful conclusions about efficacy. In the DDR group, there were no statistically significant differences between groups in any outcome at 1 or 2 months. At 3 and 6 months, 2 of 7 reported outcomes were significantly better in the hyaluronic acid group compared with the placebo group. At 5 months, 5 of 7 reported outcomes were significantly better in the hyaluronic acid group. The 7 outcomes included 3 measures of dysfunction, 2 measures of patient perception of improvement, 2 measures of change in noise. The most consistent between-group differences in the DDR group were for the 2 measures of patient perception of improvement and 1 of the noise variables. There were fewer between-group differences on dysfunction measures.
Summary
The evidence on diagnosis of TMJ dysfunction supports the use of several diagnostic modalities, as listed in the policy statement. The evidence on treatment of TMJ dysfunction includes a large number of RCTs evaluating different treatment modalities, and systematic reviews of these RCTs. Based on this evidence and clinical guidelines, certain treatment modalities may be considered medically necessary, as listed in the policy statements and other treatments are considered investigational.
Practice Guidelines and Position Statements
American Association for Dental Research: A policy statement, revised in 2010, recommends the following for the diagnosis and treatment of TMJ disorders (21):
"It is recommended that the differential diagnosis of TMDs or related orofacial pain conditions should be based primarily on information obtained from the patient's history, clinical examination, and when indicated, TMJ radiology or other imaging procedures. The choice of adjunctive diagnostic procedures should be based upon published, peerreviewed data showing diagnostic efficacy and safety. However, the consensus of recent scientific literature about currently available technological diagnostic devices for TMDs is that except for various imaging modalities, none of them shows the sensitivity and specificity required to separate normal subjects from TMD patients or to distinguish among TMD subgroups…" "It is strongly recommended that, unless there are specific and justifiable indications to the contrary, treatment of TMD patients initially should be based on the use of conservative, reversible and evidence-based therapeutic modalities. Studies of the natural history of many TMDs suggest that they tend to improve or resolve over time. While no specific therapies have been proven to be uniformly effective, many of the conservative modalities have proven to be at least as effective in providing symptomatic relief as most forms of invasive treatment..."
American Society of Temporomandibular Joint Surgeons: Consensus clinical guidelines, published in 2001, focus on TMJ associated with internal derangement and osteoarthritis. (22) For diagnosis of this type of TMJ dysfunction, a detailed history and, when indicated, general physical examination are recommended. Imaging of the TMJ and associated structures is also recommended. Options for basic radiography to provide information on temporal bone and condylar morphology include use of plain films, panoramic films, and tomograms. Also recommended is imaging of the disc and associated soft tissue with MRI or arthrography. Other diagnostic procedures that may be indicated include computed tomography, MRI, arthrography (for selected cases) and isotope bone scans.
Nonsurgical treatment should be considered first for all symptomatic patients with this condition. Recommended treatment options include change in diet, nonsteroidal antiinflammatory drugs, maxillomandibular appliances, physical therapy, injections of corticosteroids or botulinum toxin, and behavior modification. If adequate symptom relief does not occur within 2 to 3 weeks, surgical consultation is advised. The guideline states that the following surgical procedures are considered to be accepted and effective for patients with TMJ associated with internal derangement/osteoarthritis:
• Arthrocentesis
• Arthroscopy
• Condylotomy
• Arthrotomy (prosthetic joint replacement may be indicated in selected patients who have severe joint degeneration, destruction, or ankylosis)
• Coronoidotomy/coronoidectomy
• Styloidectomy
American Dental Association: Selected statements from their dental practice parameters for TMJ, revised in 1997,(23) are:
• The key element in the design of this set of parameters for temporomandibular (TM) disorders is the professional judgment of the attending dentist, for a specific patient, at a specific time.
• Initially the dentist should select the least invasive and most reversible therapy that may ameliorate the patient's pain and/or functional impairment.
• Any treatment performed should be with the concurrence of the patient and the dentist… • The dentist should evaluate the effectiveness of initial therapy prior to considering more invasive and/or irreversible therapy.
• The dentist should counsel the patient that TM disorders are often managed, rather than resolved, and that symptoms of TM disorders may persist, change, or recur intermittently.
• The patient should be informed that the success of treatment is often dependent upon patient compliance with prescribed treatment and recommendations for behavioral modifications. Lack of compliance should be recorded.
• When articular derangement and/or condylar dislocation has been determined to be the etiology of the patient's pain and/or functional impairment, manual manipulation of the mandible may be performed by the dentist.
• Oral orthotics (guards/splints) may be used by the dentist to enhance diagnosis, facilitate treatment or reduce symptoms.
• The dentist should periodically evaluate oral orthotics (guards/splints) for their effectiveness, appropriateness and possible risks associated with continued use.
• Before restorative and/or occlusal therapy is performed, the dentist should attempt to reduce, through the use of reversible modalities, the neuromuscular, myofascial and temporomandibular joint symptoms.
• The dentist may replace teeth, alter tooth morphology and/or position by modifying occluding, articulating, adjacent or approximating surfaces, and by placing or replacing restorations (prostheses) to facilitate treatment.
• Transitional or provisional restorations (prostheses) may be utilized by the dentist to facilitate treatment.
• Intracapsular and/or intramuscular injection, and/or arthrocentesis may be performed for diagnostic and/or therapeutic purposes.
• Orthodontic therapy may be utilized to facilitate treatment.
• Orthognathic surgery may be performed to facilitate treatment.
• When internal derangement or pathosis has been determined to be the cause of the patient's pain and/or functional impairment, arthroscopic or open resective or reconstructive surgical procedures may be performed by the dentist.
U.S. Preventive Services Task Force
TMJ dysfunction is not a preventive service.
Medicare National Coverage
There is no national coverage determination (NCD). In the absence of an NCD, coverage decisions are left to the discretion of local Medicare carriers. 
Blue Cross

Coding
This Policy relates only to the services or supplies described herein. Benefits may vary according to benefit design; therefore, contract language should be reviewed before applying the terms of the Policy. Inclusion or exclusion of a procedure, diagnosis or device code(s) does not constitute or imply member coverage or provider reimbursement.
MN/IE
The following service/procedure may be considered medically necessary in certain instances and investigational in others. Services may be medically necessary when policy criteria are met. Services are considered investigational when the policy criteria are not met or when the code describes application of a product in the position statement that is investigational. Other manipulation of temporomandibular joint 80. 20 Arthroscopy, unspecified site 80.51
Excision of intervertebral disc 81.91 Arthrocentesis 87. 12 Other dental x-ray 87. 13 Temporomandibular contrast arthrogram 87. 16 Other All Diagnoses
ICD-10 Diagnosis
For dates of service on or after 10/01/2015 All Diagnoses
IE
The following services are considered investigational and therefore not covered for any indication. 
Type
93.35
Other heat therapy 93.39
Other physical therapy
ICD-10 Procedure
For dates of service on or after 10/01/2015 None
ICD-9 Diagnosis
All Diagnoses
ICD-10 Diagnosis
Policy History
This section provides a chronological history of the activities, updates and changes that have occurred with this Medical Policy. 
Effective Date
Definitions of Decision Determinations
Medically Necessary: A treatment, procedure or drug is medically necessary only when it has been established as safe and effective for the particular symptoms or diagnosis, is not investigational or experimental, is not being provided primarily for the convenience of the patient or the provider, and is provided at the most appropriate level to treat the condition.
Investigational/Experimental: A treatment, procedure or drug is investigational when it has not been recognized as safe and effective for use in treating the particular condition in accordance with generally accepted professional medical standards. This includes services where approval by the federal or state governmental is required prior to use, but has not yet been granted.
Split Evaluation: Blue Shield of California / Blue Shield of California Life & Health Insurance
Company (Blue Shield) policy review can result in a Split Evaluation, where a treatment, procedure or drug will be considered to be investigational for certain indications or conditions, but will be deemed safe and effective for other indications or conditions, and therefore potentially medically necessary in those instances.
Prior Authorization Requirements
This service (or procedure) is considered medically necessary in certain instances and investigational in others (refer to policy for details).
For instances when the indication is medically necessary, clinical evidence is required to determine medical necessity.
For instances when the indication is investigational, you may submit additional information to the Prior Authorization Department.
Within five days before the actual date of service, the Provider MUST confirm with Blue Shield that the member's health plan coverage is still in effect. Blue Shield reserves the right to revoke an authorization prior to services being rendered based on cancellation of the member's eligibility. Final determination of benefits will be made after review of the claim for limitations or exclusions.
Questions regarding the applicability of this policy should also be directed to the Prior Authorization Department. Please call 1-800-541-6652 or visit the Provider Portal www.blueshieldca.com/provider.
The materials provided to you are guidelines used by this plan to authorize, modify, or deny care for persons with similar illness or conditions. Specific care and treatment may vary depending on individual need and the benefits covered under your contract. These Policies are subject to change as new information becomes available.
